在ESCC和子宫癌中共享的化学抵抗基因:从药物基因组学和孟德尔随机化中的见解
Ziyu Liu1, Jie Liu2, Yanhao Wu3
1Department of Pathology, Xiangya Hospital, Central South University, Changsha City, Hunan Province, China; Department of Pathology, School of Basic Medicine, Central South University, Changsha City, Hunan Province, China; FuRong Laboratory, Changsha City, Hunan Province, China.
International immunopharmacology
|January 4, 2025
概括
食道状细胞癌 (ESCC) 和宫癌中的化疗耐药性与CD8+ T效应记忆 (TEM) 细胞有关. 这项研究确定了IL32,SPOCK1和TRBC2作为关键基因,与对常见化疗药物的耐药性有关.
科学领域:
- 基因组学和免疫学
- 药物基因组学 药物基因组学
- 癌症研究 癌症研究
背景情况:
- 使用化合物和税的新辅助化疗对诸如宫癌和ESCC等上皮癌至关重要.
- 耐药性仍然是治疗这些癌症的主要障碍.
- 药物基因组学和门德尔随机化 (MR) 为个性化医学提供了新的方法来理解对药物反应的遗传影响.
研究的目的:
- 调查导致ESCC和宫癌化学疗法耐药性的遗传因素.
- 识别与对基药物和纳税素耐药性相关的特定基因.
- 探索CD8+ T效应体记忆 (TEM) 细胞在化学抵抗中的作用.
主要方法:
- 单细胞RNA测序 (scRNA-seq) 用于识别相关的细胞群.
- 使用全基因组关联研究 (GWAS) 数据的双样本孟德尔随机化 (MR).
- 统计分析包括沃尔德比率,逆方差加权,MR-Egger和加权中位数方法.
- 使用MTT和免疫组织化学分析进行验证.
主要成果:
- 在抗化疗样本中发现CD8+ TEM细胞的比例更高.
- 在MR中,IL32,SPOCK1和TRBC2被确定为关键基因,与对西斯普拉丁,卡博普拉丁和帕克利塔塞尔的耐药性有关.
- 这些发现在多个队伍中得到了验证,证实了CD8+TEM细胞的作用,并确定了基因对药物反应的作用.
结论:
- CD8+ TEM细胞在ESCC和宫癌中的化学抵抗中发挥着重要作用.
- IL32,SPOCK1和TRBC2被确定为对常见化疗剂耐药性的遗传标记物.
- 这些发现为个性化治疗策略铺平了道路,以提高治疗疗效和克服耐药性.
相关概念视频
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K


